MNPR
Monopar TherapeuticsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
MNPR fundamentals
Monopar Therapeutics (MNPR) released its earnings on Aug 12, 2025: revenue was -- (YoY 0.00%), beat estimates; EPS was -0.35 (YoY -250.00%), beat estimates.
Revenue / YoY
--
0.00%
EPS / YoY
-0.35
-250.00%
Report date
Aug 12, 2025
Earnings Call
8:15 AM on Aug 12, 2025
Meeting link.EPS
Revenue
Revenue & Expenses
Key Indicators
Monopar Therapeutics (MNPR) key financial stats and ratios, covering profitability, financial health, and leverage.
Monopar Therapeutics (MNPR)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Monopar Therapeutics (MNPR)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Monopar Therapeutics (MNPR)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Monopar Therapeutics (MNPR) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Monopar Therapeutics (MNPR) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
